Announcement

Admissions open for 2026-27. Apply now to secure your seat.

Dr. Ajit Kulkarni

POSITION

Dean

DEPARTMENT

School of Pharmacy

Bio

Passionate about academic leadership, faculty development, and nurturing a research-informed industry-responsive academic ecosystem.

Awards and Achievements

  • Adjudged "Best Teacher" at Satara College of Pharmacy, Satara (2004-2005)
  • Recipient of Prof. S.B. Sonawane Memorial Award for Best Research Paper in IJPER (2007)
  • Awarded as Ambassador of Universal Human Values by Bahai Academy, Panchgani (13.03.2023)

Areas of Research

Key areas:
  • Disciplinary: Novel and platform Drug Delivery Systems
  • Interdisciplinary : Bioemulsifier applications in pharmaceuticals

Research and Publications

International Publications

  1. Kulkarni AS, Bhatia MS. Design of floating bilayer tablets of Diltiazem hydrochloride and Lovastatin. PDA J Pharm Sci Technol. 2008 Sep-Oct;62(5):344-353. Impact factor 0.9 (Thompson Reuters). Pubmed indexed
  2. Kulkarni AS, Bhatia MS. Development and evaluation of regioselective bilayer floating tablets of Atenolol and Lovastatin for biphasic release profile. Iran J Pharm Res. 2009;8(1):15-25. Impact factor 1.352 (Thompson Reuters). Pubmed indexed
  3. Kulkarni AS, Gaja J. Formulation and evaluation of liquisolid compacts of Diclofenac sodium. PDA J Pharm Sci Technol. 2010;64:222-232. Impact factor 0.9 (Thompson Reuters). Pubmed indexed
  4. Kulkarni AS, Ghadge DM, Kokate PB. Formulation and in vitro evaluation of orally disintegrating tablets of Olanzapine-2Hydroxypropyl-Beta-Cyclodextrin inclusion complex. Iran J Pharm Res. 2010;9(4):335-347. Impact factor 1.352 (Thompson Reuters). Pubmed indexed
  5. Liquisolid compacts:   A review.   A.S.Kulkarni,   J.B.Gaja,   International   journal of Pharmaceutical Science and Nanotechnology,3(1), April-June 2010,795-802. ISSN: 0974- 3278.
  6. Kulkarni AS, Jadhav SD, Khetmar SS, Bhatia MS. Development of chromatographic technique for simultaneous estimation of Lovastatin and Diltiazem HCl. Mahidol Univ J Pharm Sci. 2012;39(3-4):17-23. ISSN: 0125-1570.
  7. Walsangikar SD, Kulkarni AS. Angiogenesis inhibitors targets for cancer treatment. Int J A PS BMS. 2013 Jan-Mar;2(1):52-60. Impact factor 0.37 (Thompson Reuters). ISSN 2277-9280.
  8. Kulkarni AS, Karande KM, Aloorkar NH, Suryavanshi JS. Green synthesis of nanosilver and its effect on phase solubility of few BCS class II drugs. World J Pharm Res. 2014;3(6):440-456. Impact factor 6.805 (SJIF). ISSN 2277-7105.
  9. Kulkarni AS, Majumdar SH, Aloorkar NH, Karande KM, Dhayagude SN. Exploring "Samudra-Fen" as an alternative excipient in the manufacturing of fast disintegrating tablet. World J Pharm Res. 2014;3(7):429-452. Impact factor 6.805 (SJIF). ISSN 2277-7105.
  10. Harkare BR, Kulkarni AS, Aloorkar NH, Majumdar SH. Effect of Mannitol and MCC on rapidly disintegrating tablets. World J Pharm Res. 2014;3(6):440-456. Impact factor 6.805 (SJIF). ISSN 2277-7105.
  11. Kulkarni AS, Majumdar SH, Aloorkar NH, Karande KM, Kodalkar DD. Study of cross-linked sodium Rboxymethylcellulose (Nacmc) as an alternative superdisintegrant in fast dissolving formulation. World J Pharm Res. 2014;3(7):396-409. Impact factor 6.805 (SJIF). ISSN 2277-7105.
  12. Osmani RA, Aloorkar NH, Kulkarni AS, Kulkarni PK, Hani U, Tirumaleshwar S, Bhosale R. Novel cream containing microsponges of anti-acne agents: Formulation development and evaluation. Curr Drug Deliv. 2015;12(5):504-516. Impact factor 2.248 (Thompson Reuters). ISSN 1875-5704. Pubmed indexed
  13. Shewale S, Shirke S, Aloorkar N, Kulkarni A, Majumdar SH, Shete A. Pharmaceutical co-crystal: Design, development and characterization. Am J PharmTech Res. 2015;5(4):90-107. Impact factor 0.9832 (Universal). ISSN 2249-3387.
  14. Shirke SH, Shewale SB, Kulkarni AS, Aloorkar NH. Solid dispersion: A novel approach for poorly water soluble drugs. Int J Curr Pharm Res. 2015;7(4):1-8. Impact factor 4.5 (SJIF). ISSN 975-7066.
  15. Medhekar SK, Jadhav TP, Sasane VS, Shende VS, Aloorkar NH, Chincholkar AB, Soman GS, Kulkarni AS. Protective effect of Tritone (Livosone) on oxidative DNA damage and its hepatoprotective potential against various hepatotoxic agents in Wistar rats. Exp Toxicol Pathol. 2017;69:153-161. Impact factor 1.716 (Thompson Reuters). DOI: 10.1016/j.etp.2016.12.005. Pubmed indexed
  16. Pattekari SN, Kulkarni AS. Solubility and dissolution enhancement of a BCS class II drug by co-grinding with superdisintegrants. Indo Am J Pharm Res. 2017;7(04).
  17. Kasabe AJ, Kulkarni AS, Gaikwad VL. Bioanalytical method development and validation for estimation of formulated sustained release tablet of Nateglinide in rabbit plasma. Int J Pharm Res. 2019;11(1):347-357. Impact factor 0.13 (Scopus Indexed). ISSN 0975-2366.
  18. Kulkarni AS, Kasabe AJ, Bhatiya MS, Bhatiya MN, Gaikwad VL. Quantitative structure-property relationship approach in formulation development: An overview. AAPS PharmSciTech. 2019;20(7):268. Impact factor 2.68 (Thompson Reuters). DOI: 10.1208/s12249-019-1480-2. Pubmed indexed
  19. Kasabe AJ, Kulkarni AS, Gaikwad VL. QSPR modeling of biopharmaceutical properties of hydroxypropyl methylcellulose (cellulose ethers) tablets based on its degree of polymerization. AAPS PharmSciTech. 2019;20:308. Impact factor 2.68 (Thompson Reuters). DOI: 10.1208/s12249-019-1514-9. Pubmed indexed
  20. Gurav AS, Kulkarni AS. Efavirenz cocrystals with ascorbic acid: A strategy for polymorphic modification and improvement of dissolution properties. Res J Pharm Technol. 2023;17(1):213-221.
  21. Gurav AS, Kulkarni AS. Design, development and evaluation of stable valsartan nanocrystals with chitosan using microwave-assisted grinding nanotechnology. Int J Pharm Sci Res. 2023;14(6):2835-2847.

National Publications

  1. Manvi FV, Hiremath SP, NANJWADE B, KULKARNI A, CHALIKWAR S. Formulation and evaluation of dispersible tablets of flurbiprofen. The Indian Pharmacist. 2005;4(32):68-71.
  2. Ligade V, Kulkarni A, Kokil SU, Dias R. Antiepileptic drugs: Neurologists Perception. Antiseptic. 2007;103:160-162.
  3. Kokil SU, Ligade VS, Kulkarni AS, Dias RJ. Evaluation of cyclic glycolamide conjugates of acetyl salicylic acid. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH. 2007 Jul 1;41(3):219-23. ISSN 019-5484 Impact factor (Thompson Reuters) 0.27
  4. Ligade VS, Sreedhar D, Manthan J, Ajay P, Khadase S, Kokil S, Kulkarni A. Intensifying role of Pharmacist in National Service Scheme. Indian J Hosp Pharm. 2007 Sep-Oct;44(5):178-180. ISSN 2348-7704
  5. Kulkarni AS, Bhatia MS, Mohite RK, Deshmukh RM. Simultaneous estimation of Diltiazem HCl and Lovastatin form combined dosage form by spectrophotometric method. Asian J Pharm. Oct-Nov-2007. ISSN 973- 8398, Impact factor (Thompson Reuters) 0.284
  6. Havaldar VD, Kulkarni AS, Dias RJ, Mali KK. Optimization and in vitro evaluation of floating tablets of Atenolol. J Pharm Res. 2008 Jul-Sep;1(1):73-78. ISSN 974-6943 Impact Factor (Thompson Reuters) 0.7
  7. Havaldar VD, Kulkarni AS, Dias RJ, Aloorkar NH, Mali KK. Floating matrix tablets of Atenolol: formulation and in vitro evaluation. Asian J Pharm. 2009;3:286-91, ISSN 973-8398, Impact factor (Thompson Reuters) 0.284
  8. Kulkarni AS, Deokule HA, Mane MS, Ghadge DM. Exploration of different polymers for use in the oral fast dissolving strips. JCPR. 2010;2(1):33-35. ISSN 2230-7834 Impact factor (Thompson Reuters) 1.0488
  9. Bobade CD, Kulkarni AS. Floating pulsatile drug delivery system of captopril based on impermeable cylinder. Inventi Rapid NDDS. 2011;2(2), ISSN 976-3791
  10. Ghodake PP, Kulkarni AS, Aloorkar NH, Osmani RA, Bhosale RR, Harkare BR, Kale BB. In-vitro antispasmodic activity analysis of methanolic leaves extract of Lantana camara Linn. on excised rat ileum. J Pharmacogn Phytochem. 2013;2(3):66-71. ISSN 2349-8234 Impact factor (Global) 0.255
  11. Kulkarni AS, Gilda SS, Alurkar NH, Bhosale RR, Osmani RA. Development of novel formulation containing propolis for mastitis. Int J Drug Deliv Technol. 2013;3(1):12-22. Impact factor 1.221 ISSN 975- 4415
  12. Kulkarni AS, Majumdar S, Aloorkar NH, Gilda SS, Gharge PS. Isolation of the mucilage from seeds of Astercantha longifolia and study the effects of its mucilage as pharmaceutical excipient. J Adv Drug Deliv. 2015;2(2). Impact factor (ISRA) 0.46.ISSN 2348-3792.
  13. Shende VS, Jadhav SD, Aloorkar NH, Kulkarni AS, Suryavanshi SV. Pharmacognostic and phytochemical evaluation of Strobilanthes sessilis Nees leaves. Int J Pharmacogn. 2015;2(6):310-314. ISSN 2348-5962
  14. Bhise SH, Surve BS, Aloorkar NH, Majumdar SH, Kulkarni AS. Pulsatile drug delivery of chitosan coated beads of miglitol with fast dissolving limepiride tablet. J Chem Pharm Res. 2015;7(12):295-304. ISSN- 975-7384
  15. Chavare SD, Karande KM, Aloorkar NH, Kulkarni AS, Majumdar SH. Formulation of novel herbal mosquito repellent: A new approach in antimalarial management. Int J MediPharm Res. 2015;1(2):78-85. ISSN 2395- 423X
  16. Majumdar SH, Kulkarni AS, Aloorkar NH, Shinde MD. Exploring Shat Dhaut Ghrita as formulation base for the topical delivery of Curcuma amada. Indo Am J Pharm Res. 2016;6(7):6243-6249. ISSN 2231-6876 Impact factor 2.37
  17. Kulkarni A, Mandhare T, Aloorkar N. Application of novel natural polymer for controlling the release of fenoverine from controlled release matrix tablets. Int J Appl Sci. 2017;9(2):1-9. Scopus indexed, DOI 10.22159/ijap.2017v9i2.16318 ISSN 0975-7058. Impact factor 0.67( SJR)
  18. Hagir D, Kulkarni A, Mahadar S, Gothal V. Design, development and evaluation of emulsion drug delivery of fluconazole based on excipient obtained from natural source and comparative evaluation studies with existing emulsifying agent. Int J Univ Pharm Bio Sci. 2016;5(4):147-165.
  19. Kasabe AJ, Kulkarni AS, Gaikwad VL. Compatibility testing of nateglinide with different grades of cellulose ethers and excipients used in sustained release formulations. Int J Drug Deliv Technol. 2018;8(4):197-211. ISSN: 0975 4415
  20. Yadav KS, Kulkarni AS. Formulation and evaluation of Samudrafen transdermal drug delivery system. Adv Bioresearch. 2020;11(5):47-55.
  21. Kulkarni A, Madane T, Aloorkar N, Majumdar S. Enhancement of solubility of BCS class II drug (Pioglitazone) using natural polymer (Pullulan). J Curr Pharma Res. 2019;9(4):3321-3334.
  22. Majumdar SH, Kulkarni AS, Adsule PV. The effect of surfactant on developed ophthalmic drug delivery system for the delivery of antifungal drug in posterior segment of eye. Int Res J Pharm Med Sci. 2018;1(2):1-6.
  23. Kulkarni A, Dhasade V, Ingle V, Kasabe A, Yadav A, Fattepur S, Sreeharsha N, Bhavya E. HPMC polymeric system: Structural contribution in controlling drug release in sustained drug delivery systems. Int J Pharm Res. 2021;13(1):2031-2039. ISSN 0975-2366, DOI : https://doi.org/10.31838/ijpr/2021.31.01.325
  24. Sakhare S, Chavan S, Gurav P, Kharat R, Kulkarni A. Isolation, characterization, chemical modification and application of Echinochloa colona starch as tablet disintegrant. Int J Pharm Sci Nanotechnol. 2021;14(4):5529-5537. ISSN Print: 0974-3278. https://doi.org/10.37285/ijpsn.2021.14.4.2
  25. Dada Kodalkar1*, Ajit Kulkarni2 , Birendra Shrivastav3 , Harshal Tare4, Preparation, Characterization of Bacterial Cellulose and Chlordiazepoxide Tablets for Oral Drug Delivery, International Journal of Pharmaceutical Quality Assurance, , Volume 13 Issue 4, October - December 2022, 408-412
  26. A. S. Gurav and A. S. Kulkarni., Preparation and Optimization of Microwave-Assisted BallMilled Olmesartan Medoxomil with Chitosan Using Full 32 Factorial Design., Ind. J. Pharm. Edu. Res., 2023; 57(3s):s555-s563.

Review Articles 

  1. Medicated Chewing Gums-A Travel Friendly Dosage Form, A.S.Kulkarni, R.J.Dias N.H.Aloorkar and K.K.Mali, Indian Pharmacist, Sept. 2005.
  2. Kulkarni AS, Bothiraja C, Shinde MB, Rajalakshmi S. Nail Drug Delivery System. Indian J Pharm Educ Res. 2006 Oct-Dec;40(4):264-268. ISSN 019-5484 Impact factor (Thompson Reuters) 0.27
  3. Aloorkar NH, Kulkarni AS, Ingale DJ, Patil RA. Microsponges as innovative drug delivery systems. Int J Pharm Sci Nanotechnol. 2012 Apr;5(1):1597-606. ISSN: 0974-3278
  4. Bobade C, Kulkarni A, Chaudhari V. A Review on Types and Methodologies of Pulsatile Drug Delivery System. Int J Pharm Chem Sci. 2012 Jul-Sep;1(3):923-932. ISSN 2277- 5005
  5. Patil RA, Aloorkar NH, Kulkarni AS, Ingale DJ. Star polymers: An overview. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2012 Aug 31;5(2):1675-84.
  6. Kulkarni AS, Gilda SS, Aloorkar NH, Bhosale RR, Osmani RA, Ghodke PP. Magnetic nanoparticles: A novel plethora in Advanced Drug Delivery. Int J Innov Pharm Sci. 2013;2(5):73-79.  ISSN 2319- 5223 Impact Factor (SJIF) 3.268
  7. Harkare BR, Kulkarni AS, Aloorkar NH, Suryawanshi JS, Wazarkar AS, Osmani RA. Nanocochleate: A New Cornucopia In Oral Drug Delivery. Int J Innov Pharm Sci. 2013;2(4):1-9. Impact Factor (SJIF) 3.268
  8. Bhosale RR, Kulkarni AS, Gilda SS, Aloorkar NH, Osmani RA, Harkare BR. Innovative Eco-Friendly approaches for Green Synthesis of Silver nanoparticles. Int J Pharm Sci Nanotechnol. 2014 Jan-Mar;7(1):2328-2337..
  9. Osmani RA, Aloorkar NH, Kulkarni AS, Harkare BR, Bhosale RR. A New Cornucopia in topical drug delivery: Microsponge Technology. Asian J Pharm Sci Technol. 2014;4(1):48-60. Impact factor 0.284 ISSN 2248-9185
  10. Shinde NG, Aloorkar NH, Kulkarni AS. Recent advances in vesicular drug delivery systems. Res J Pharm Dosage Forms Technol. 2014 Mar;6(2):975-4377..ISSN 0975-4377
  11. Shinde N, Aloorkar N, Kulkarni A, Bangar B, Sulake S, Kumbhar P. Recent advances in granulation techniques. Asian J Pharm Sci. 2014;4(1):38-47..ISSN 1818-0876
  12. Osmani RM, Kulkarni AS, Aloorkar NH, Bhosale RR, Ghodake PP, Harkare BR. Carbon nanotubes: An impending carter in therapeutics. Int J Pharm Clin Res. 2014;6(1):84-96. Impact factor 1.668 ISSN 975- 1556
  13. Shinde N, Aloorkar NH, Kulkarni AS, Bhagyashree SS, Savita HB, Sharad ND. Advances in gastroretentive drug delivery system: A review. Int J Pharm Pharm Sci Res. 2014;4(2):37-48. ISSN 2249-0337
  14. Ghadge TA, Kulkarni AS, Majumdar SH, Chavare SD. Ethosome: A promising approach for antifungal drug delivery. Res J Topical Cosmet Sci. 2015;6(1):1-6. ISSN 2321-5844
  15. Karande KM, Kulkarni AS, Surve BS. Challenges to the pharmacists across the few developed countries: A brief review. Int J Curr Pharm Sci. 2014;1(2):127-129.
  16. Ghadge TA, Chavare SD, Kulkarni A, Kamble S. A review on parenteral implants. Int J Res Rev Pharm Appl Sci. 2014;4(2):1056-1072. Impact factor 1.15, ISSN 2249-1236.
  17. Kulkarni AS, Kodalkar DD, Yadav AV, Bangar BN, Majumdar SH. A review on “new generation excipients of multifunctional noval dosage form”. World Journal of Pharmaceutical Research. 2017 Jul 2:174-83.
  18. Chincholkar AB, Shende VS, Medhekar SK, Aloorkar NH, Kulkarni AS. Current approaches to treat Huntington’s disease – A review. Indo Am J Pharm Res. 2017;7(9):478-487.
  19. Majumdar SH, Kulkarni AS, Kumbhar SM. Yogvahi (bioenhancer): an Ayurvedic concept used in modern medicines. International Research Journal of Pharmacy and Medical Sciences. 2018;1:20-5.
  20. Kulkarni A, Dhasade V, Ingle V, Kasabe A, Yadav A, Fattepur S, Sreeharsha N. Bioinformatics applied to drug development and discovery: An overview. Int J Pharm Res. 2020;12(2):4375-4385. ISSN 0975-2366, DOI:  https://doi.org/10.31838/ijpr/2020.SP2.549